Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Cipla plans to launch Molnupiravir under brand name Cipmolnu Roshni Dhar31 Dec 2021 5:01 PM ISTCipla Limited announced that the company has been granted permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in...
Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 5:59 PM ISTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 3:00 PM ISTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
Decoding Molnupiravir for Non hospitalized COVID-19 Patients Dr. Kamal Kant Kohli24 Dec 2021 12:15 PM ISTIn the Covid-19 pandemic, a substantial portion of patients need hospitalization, predominantly older adults and persons with preexisting conditions...
